Jinhuan Luo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jinhuan Luo has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Chuanling Zhang
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China; Shenzhen Bay Laboratory, Gaoke International Innovation Center, Shenzhen, Guangdong, 518107, China; Peking University Ningbo Institute of Marine Medicines, Ningbo, Zhejiang, 315832, China; Peking University - Yunnan Baiyao International Medical Research Center, Beijing, 100191, China
1 shared publication - Demin Zhou
Peking University
1 shared publication Dezhong Ji
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China; Shenzhen Bay Laboratory, Gaoke International Innovation Center, Shenzhen, Guangdong, 518107, China; Peking University Ningbo Institute of Marine Medicines, Ningbo, Zhejiang, 315832, China; Peking University - Yunnan Baiyao International Medical Research Center, Beijing, 100191, China
1 shared publicationFudi Wang
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China; Shenzhen Bay Laboratory, Gaoke International Innovation Center, Shenzhen, Guangdong, 518107, China; Peking University Ningbo Institute of Marine Medicines, Ningbo, Zhejiang, 315832, China; Peking University - Yunnan Baiyao International Medical Research Center, Beijing, 100191, China
1 shared publicationJiawen Zhang
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China; Shenzhen Bay Laboratory, Gaoke International Innovation Center, Shenzhen, Guangdong, 518107, China; Peking University Ningbo Institute of Marine Medicines, Ningbo, Zhejiang, 315832, China; Peking University - Yunnan Baiyao International Medical Research Center, Beijing, 100191, China
1 shared publication- John W. Hickey
Duke University
1 shared publication
Latest Publications
- Open Access
- 13 October 2026
- Published by Springer Nature in Nature Methods
- Vol. 23 (11) , 2274-2285
Near-infrared photochromic miniprotein enables photoacoustic molecular imaging of acute inflammation and intracellular antigens
Using near-infrared photoswitchable photochromic genetically encoded probes, differential photoacoustic tomography (PAT) enables deep-tissue imaging with high resolution and sensitivity; however, current bacteriophytochrome-based probes are bulky multidomain proteins exceeding 55 kDa, which constrains their use for designing PAT molecular reporters. Here we engineer rsmiRFPnano, a compact cyanobacteriochrome-derived photoswitchable PAT probe. With a molecular weight below 19 kDa, rsmiRFPnano efficiently incorporates biliverdin, exhibits high extinction coefficients in both photochromic states and demonstrates robust performance in live cells. We established rsmiRFPnano-based reporters for NF-κB and AP-1 pathways, which display low basal activity and strong activation-dependent responses. These reporters effectively visualized acute inflammation using noninvasive PAT in vivo, further validated through cellular-level spatial omics mapping. We then created photoswitchable nanobody probes, rsNIR-Fbs, stabilized upon antigen binding and rapidly degraded otherwise, enabling selective photoacoustic immuno-imaging of intracellular antigens in vivo. Together, these results establish rsmiRFPnano as an ultracompact and versatile platform for molecular PAT.
- 13 October 2026
- Published by Springer Nature in Nature Methods
- Vol. 23 (11) , 2274-2285
Open AccessNear-infrared photochromic miniprotein enables photoacoustic molecular imaging of acute inflammation and intracellular antigens
Using near-infrared photoswitchable photochromic genetically encoded probes, differential photoacoustic tomography (PAT) enables deep-tissue imaging with high resolution and sensitivity; however, current bacteriophytochrome-based probes are bulky multidomain proteins exceeding 55 kDa, which constrains their use for designing PAT molecular reporters. Here we engineer rsmiRFPnano, a compact cyanobacteriochrome-derived photoswitchable PAT probe. With a molecular weight below 19 kDa, rsmiRFPnano efficiently incorporates biliverdin, exhibits high extinction coefficients in both photochromic states and demonstrates robust performance in live cells. We established rsmiRFPnano-based reporters for NF-κB and AP-1 pathways, which display low basal activity and strong activation-dependent responses. These reporters effectively visualized acute inflammation using noninvasive PAT in vivo, further validated through cellular-level spatial omics mapping. We then created photoswitchable nanobody probes, rsNIR-Fbs, stabilized upon antigen binding and rapidly degraded otherwise, enabling selective photoacoustic immuno-imaging of intracellular antigens in vivo. Together, these results establish rsmiRFPnano as an ultracompact and versatile platform for molecular PAT.
- 11 June 2026
- Published by Elsevier in Biomaterials
- Vol. 335, 124381
Precision glycoengineered AAV capsids enhance hepatocyte targeting and attenuated immune activation for liver-directed gene therapy
- 11 June 2026
- Published by Elsevier in Biomaterials
- Vol. 335, 124381
Precision glycoengineered AAV capsids enhance hepatocyte targeting and attenuated immune activation for liver-directed gene therapy